Mirae Asset Global ETFs Holdings’s Definium Therapeutics DFTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.82M	Buy	59,936 +13,743	+30%	+$340K	﹤0.01%	1087
2026 Q1	$873K	Buy	46,193 +2,457	+6%	+$41.7K	﹤0.01%	1579
2025 Q4	$586K	Buy	43,736 +8,339	+24%	+$103K	﹤0.01%	1808
2025 Q3	$417K	Sell	35,397 -5,864	-14%	-$54.7K	﹤0.01%	1949
2025 Q2	$268K	Sell	41,261 -2,289	-5%	-$15.1K	﹤0.01%	2129
2025 Q1	$255K	Sell	43,550 -2,140	-5%	-$15.3K	﹤0.01%	2193
2024 Q4	$318K	Buy	45,690 +6,182	+16%	+$42.5K	﹤0.01%	2139
2024 Q3	$225K	Buy	+39,508	New	+$275K	﹤0.01%	2318

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's DFTX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Definium Therapeutics (DFTX) stake by 30% in Q2 2026, buying an estimated $340K and bringing the position to 59,936 shares worth $2.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Mirae Asset Global ETFs Holdings first reported a position in DFTX in Q3 2024 and has held it in 8 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 59,936 shares of Definium Therapeutics worth $2.82M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 13,743 Definium Therapeutics shares in Q2 2026, an estimated $340K.
Definium Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1087 holding.
Mirae Asset Global ETFs Holdings first reported a position in Definium Therapeutics in Q3 2024 and has held it in 8 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.